Cargando…
424 Clinical Translational Approach to Targeted Therapy in SLC6A1-related Neurodevelopmental Disorder
OBJECTIVES/GOALS: SLC6A1-Related Neurodevelopmental Disorder (SLC6A1-NDD) is a leading genetic cause of epilepsy and autism. Haploinsufficiency of SLC6A1 leads to reduced uptake of GABA from the synaptic cleft, and increased extracellular GABA in mice. It is a candidate for gene transfer therapy, bu...
Autores principales: | Goodspeed, Kimberly, Sirsi, Deepa, Gray, Steven, Rioux, Matthew, Guo, WeiRui, Iannaccone, Susan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129657/ http://dx.doi.org/10.1017/cts.2023.457 |
Ejemplares similares
-
Electroencephalographic (EEG) Biomarkers in Genetic Neurodevelopmental Disorders
por: Goodspeed, Kimberly, et al.
Publicado: (2023) -
A draft conceptual model of SLC6A1 neurodevelopmental disorder
por: Goodspeed, Kimberly, et al.
Publicado: (2023) -
Intrafamilial variability in SLC6A1-related neurodevelopmental disorders
por: Kassabian, Benedetta, et al.
Publicado: (2023) -
Current knowledge of SLC6A1-related neurodevelopmental disorders
por: Goodspeed, Kimberly, et al.
Publicado: (2020) -
Corrigendum: Intrafamilial variability in SLC6A1-related neurodevelopmental disorders
por: Kassabian, Benedetta, et al.
Publicado: (2023)